These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28414198)

  • 21. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.
    Al-Rasheed NM; Al-Rasheed NM; Bassiouni YA; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mahmoud AM
    Biomed Pharmacother; 2018 Sep; 105():290-298. PubMed ID: 29860221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slit2/Robo1 signaling is involved in angiogenesis of glomerular endothelial cells exposed to a diabetic-like environment.
    Liu J; Hou W; Guan T; Tang L; Zhu X; Li Y; Hou S; Zhang J; Chen H; Huang Y
    Angiogenesis; 2018 May; 21(2):237-249. PubMed ID: 29299781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
    Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
    Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA MALAT1 mediates high glucose-induced glomerular endothelial cell injury by epigenetically inhibiting klotho via methyltransferase G9a.
    Li Y; Ren D; Xu G
    IUBMB Life; 2019 Jul; 71(7):873-881. PubMed ID: 30762931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy.
    Barzegar-Fallah A; Alimoradi H; Razmi A; Dehpour AR; Asgari M; Shafiei M
    Eur J Pharmacol; 2015 Nov; 767():152-9. PubMed ID: 26481166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney.
    Zhu K; Kakehi T; Matsumoto M; Iwata K; Ibi M; Ohshima Y; Zhang J; Liu J; Wen X; Taye A; Fan C; Katsuyama M; Sharma K; Yabe-Nishimura C
    Free Radic Biol Med; 2015 Jun; 83():21-30. PubMed ID: 25701431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
    Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats.
    Jiang B; Guo L; Li BY; Zhen JH; Song J; Peng T; Yang XD; Hu Z; Gao HQ
    J Med Food; 2013 Jun; 16(6):481-6. PubMed ID: 23767859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.
    Liu Y; Xu Z; Ma F; Jia Y; Wang G
    Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT1 mediates podocyte injury and glomerular fibrosis through phosphorylation of ERK pathway.
    Zhu Y
    Biochem Biophys Res Commun; 2018 Jan; 495(1):828-838. PubMed ID: 29129692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy.
    Tunçdemir M; Oztürk M
    Acta Histochem; 2011 Dec; 113(8):826-32. PubMed ID: 21269661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
    Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
    J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice.
    Chou YJ; Kan WC; Chang CM; Peng YJ; Wang HY; Yu WC; Cheng YH; Jhang YR; Liu HW; Chuu JJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
    Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
    Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
    [No Abstract]   [Full Text] [Related]  

  • 39. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
    Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
    Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
    Yin Q; Xia Y; Wang G
    Biochem Biophys Res Commun; 2016 Sep; 477(4):881-886. PubMed ID: 27378427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.